Los Angeles Times Editorial Calls for ‘Workable Version’ of Pharmaceutical Drug Cost Disclosure Bill
"The lack of transparency about pricing is a problem throughout the health care industry, and Congress is doing little about it," leaving it to state lawmakers to pry open the health care black box," a Los Angeles Times editorial writes. For example,a bill (AB 463) by Assembly member David Chiu (D-San Francisco) that would require drugmakers to submit an annual report to the state on the costs of producing drugs with a wholesale cost of $10,000 or more per course of treatment. While acknowledging that pharmaceutical companies have some "legitimate concerns" about the bill, the editorial calls for negotiations to create "a workable version" that would shine a light on drug pricing.
- "Editorial: Bill on Drug Pricing Would Help State in Figuring Health Care Costs" (Los Angeles Times, 4/26).